Posts - CLL Support | HealthUnlocked
All posts for April 2013
Savings worth dying for?
Peter Saul, Senior Specialist in Intensive Care and Head of Clinical Unit in Eth...
Can you think yourself better? What does the evidence say?
Michael Vagg, the Clinical Senior Lecturer at Deakin University School of Medici...
Want to take advantage of all our features? Just log in!
or
Who speaks first about your cancer?
Today I received a link from Karl Schwartz of Lymphomation.org to the following ...
Clonal evolution, genomic drivers and effects of therapy in CLL
Further to the discussion on the recent posting about the carcinogenic impact of...
Cancer Survivors Also Live With Distress
'To say that a diagnosis of cancer can be stressful for patients is putting it m...
Cancer Network Interview: Understanding Spirituality and How It Can Be Used to Help Patients
In this transcript of a Cancer Network podcast, Tami Borneman RN, MSN, CNS, FPCN...
Six myths about vaccination and why they're wrong
The link below is to an interesting rebuttal of common vaccination myths which w...
Chromothripsis in CLL ....a 'Big Bang' event?
Chromothripsis is the phenomenon by which thousands of clustered chromosomal rea...
Another humanized monoclonal antibody RG7356, in development by Roche
Roche are developing RG7356, which targets CD44, a surface receptor that is over...
Updated ACOR CLL Patient's Doctors list
This list has been updated, but old links no longer work.
The new PDF file ...
Intro: Targeted drugs for Lymphoma ... what's a pathway?
Karl from USA based Patients Against Lymphoma, has just posted a brief but infor...
Introduction to targeted drugs
CLL/SLL is classified as a type of NHL by the World Health Organisation. This is...
More drug studies and trials on the way!
Good to see the search for improved CLL treatments continues:
1) A Phase 2 o...